William H. Rastetter, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 18,000 shares at $151.82 ($2.7M) on 2025-11-05, disclosed to the SEC on 2025-11-06.
Scheduled sale ($2.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NBIX | SELL | 2024-01-04 | $2.9M | — | Filing → |
| NBIX | SELL | 2023-05-03 | $872K | — | Filing → |
| NBIX | SELL | 2023-04-21 | $1.4M | — | Filing → |